Plethora of U.S., PRC firms on $3.3 bln WuXi PharmaTech take-private deal
BY Eileen Ang |
O’Melveny & Myers, Willkie Farr & Gallagher, Walkers Global and Zhong Lun Law Firm are advising NYSE-listed Chinese clinical research organization WuXi PharmaTech on its agreement to be bought by a Chinese investor consortium for $3.3 billion.